Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason A Gluck

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Artificial Organs|June 6, 2015
Systematic Review of Phosphodiesterase-5 Inhibitor Use in Right Ventricular Failure Following Left Ventricular Assist Device ImplantationWilliam L Baker, Joseph Radojevic, Jason A Gluck
Connecticut Medicine|August 6, 2015
A Survey of Knowledge and Perspectives of Ventricular Assist Device Therapy: Evaluating the Timing of Advanced Heart Failure ReferralBryan T Lawlor, Jason W Ryan, Richard J Soucier, et al.
International Journal of Antimicrobial Agents|May 16, 2022
Pharmacokinetics and Time above the MIC Exposure of Cefepime in Critically Ill Patients Receiving Extracorporeal Membrane Oxygenation (ECMO)Abigail K Kois, Jason A Gluck, David P Nicolau, et al.
Texas Heart Institute Journal|October 28, 2015
Extracorporeal Membrane Oxygenation as a Bridge to Surgery for Infective Endocarditis Complicated by Aorto-Atrial Fistula and Cardiopulmonary CollapseAdam M Noyes, Bhavadharini Ramu, Matthew W Parker, et al.
ESC Heart Failure|July 28, 2018
Left ventricular assist device implantation improves glycaemic control: a systematic review and meta-analysisNirav Patel, Jason A Gluck, Joseph Radojevic, et al.
Connecticut Medicine|October 29, 2015
The Association Between Baseline Left Atrial Volume Index and All-Cause Mortality in Patients with Heart Failure: A Meta-AnalysisBhavadharini Ramu, Ahmed M Elwan, Craig I Coleman, et al.
European Journal of Drug Metabolism and Pharmacokinetics|June 23, 2023
Cefiderocol is Not Sequestered in an Ex Vivo Extracorporeal Membrane Oxygenation (ECMO) CircuitAngela V Berry, Allison Conelius, Jason A Gluck, et al.
The Journal of Antimicrobial Chemotherapy|March 22, 2024
Imipenem/relebactam pharmacokinetics in critically ill patients supported on extracorporeal membrane oxygenationAndrew J Fratoni, Abigail K Kois, Jason A Gluck, et al.
International Journal of Antimicrobial Agents|February 19, 2025
Cefiderocol pharmacokinetics in critically-ill patients receiving extra-corporeal membrane oxygenation (ECMO)Christina Koenig, Andrew J Fratoni, Yasmeen Abouelhassan, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|February 20, 2022
Extracorporeal Life Support Organization Guideline for Transport and Retrieval of Adult and Pediatric Patients with ECMO SupportAhmed Labib, Erin August, Cara Agerstrand, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Artificial Organs|June 6, 2015
Systematic Review of Phosphodiesterase-5 Inhibitor Use in Right Ventricular Failure Following Left Ventricular Assist Device ImplantationWilliam L Baker, Joseph Radojevic, Jason A Gluck
Connecticut Medicine|August 6, 2015
A Survey of Knowledge and Perspectives of Ventricular Assist Device Therapy: Evaluating the Timing of Advanced Heart Failure ReferralBryan T Lawlor, Jason W Ryan, Richard J Soucier, et al.
International Journal of Antimicrobial Agents|May 16, 2022
Pharmacokinetics and Time above the MIC Exposure of Cefepime in Critically Ill Patients Receiving Extracorporeal Membrane Oxygenation (ECMO)Abigail K Kois, Jason A Gluck, David P Nicolau, et al.
Texas Heart Institute Journal|October 28, 2015
Extracorporeal Membrane Oxygenation as a Bridge to Surgery for Infective Endocarditis Complicated by Aorto-Atrial Fistula and Cardiopulmonary CollapseAdam M Noyes, Bhavadharini Ramu, Matthew W Parker, et al.
ESC Heart Failure|July 28, 2018
Left ventricular assist device implantation improves glycaemic control: a systematic review and meta-analysisNirav Patel, Jason A Gluck, Joseph Radojevic, et al.
Connecticut Medicine|October 29, 2015
The Association Between Baseline Left Atrial Volume Index and All-Cause Mortality in Patients with Heart Failure: A Meta-AnalysisBhavadharini Ramu, Ahmed M Elwan, Craig I Coleman, et al.
European Journal of Drug Metabolism and Pharmacokinetics|June 23, 2023
Cefiderocol is Not Sequestered in an Ex Vivo Extracorporeal Membrane Oxygenation (ECMO) CircuitAngela V Berry, Allison Conelius, Jason A Gluck, et al.
The Journal of Antimicrobial Chemotherapy|March 22, 2024
Imipenem/relebactam pharmacokinetics in critically ill patients supported on extracorporeal membrane oxygenationAndrew J Fratoni, Abigail K Kois, Jason A Gluck, et al.
International Journal of Antimicrobial Agents|February 19, 2025
Cefiderocol pharmacokinetics in critically-ill patients receiving extra-corporeal membrane oxygenation (ECMO)Christina Koenig, Andrew J Fratoni, Yasmeen Abouelhassan, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|February 20, 2022
Extracorporeal Life Support Organization Guideline for Transport and Retrieval of Adult and Pediatric Patients with ECMO SupportAhmed Labib, Erin August, Cara Agerstrand, et al.
Pageof 2